Involvement of SET in the Wnt signaling pathway and the development of human colorectal cancer.
Ontology highlight
ABSTRACT: The SET oncoprotein is involved in cancer progression by modulating multiple cellular processes, including the inhibition of the tumor suppressor, protein phosphatase 2 (PP2A). Based upon these multiple activities, we hypothesized that targeted inhibition of SET is likely to have multiple discrete and measurable effects on cancer cells. In the present study, the mRNA expression levels of SET, PP2A and β-catenin were examined in 31 pairs of human colorectal adenocarcinoma tissues and corresponding adjacent normal colorectal tissues by quantitative real-time polymerase chain reaction (qPCR). A small interfering RNA targeting SET was transfected into the human colon carcinoma cell lines, LS174T and SW480. The mRNA levels of SET, PP2A, β-catenin
SUBMITTER: Dong L
PROVIDER: S-EPMC3961466 | biostudies-literature | 2014 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA